Results 201–220 of 1415 for speaker:Seema Kennedy

Written Answers — Department of Health and Social Care: Heart Diseases and Strokes: Females (23 Jul 2019)

Seema Kennedy: Improving the prevention and treatment of heart attacks and stroke are key aims in the NHS Long Term Plan, with an important milestone being for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan highlights that outcomes from heart attack and stroke can be improved, and that there should be a focus...

Written Answers — Department of Health and Social Care: Cystic Fibrosis: Drugs (23 Jul 2019)

Seema Kennedy: Discussions with Vertex, including meetings, are ongoing. NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which...

Written Answers — Department of Health and Social Care: 5G: Health Hazards (23 Jul 2019)

Seema Kennedy: Public Health England (PHE) advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The ICNIRP guidelines cover exposures arising from new 5G base stations, as well as from older technologies. Many...

Written Answers — Department of Health and Social Care: Rehabilitation Centres: County Durham (23 Jul 2019)

Seema Kennedy: The Government provides funding to local authorities for their public health responsibilities through a public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for residential drug treatment services taking account of their statutory duties. Future funding for local authority public health...

Written Answers — Department of Health and Social Care: NHS: Drugs (23 Jul 2019)

Seema Kennedy: The costs of branded medicines are controlled by the statutory and voluntary schemes for branded medicines. Under those schemes, any price increase needs to be agreed by the Department. For generic medicines, the Department encourages competition between suppliers to drive prices down. This generally works well but there are instances where there is no or not enough competition and prices...

Written Answers — Department of Health and Social Care: Synacthen: Prices (23 Jul 2019)

Seema Kennedy: The Department agreed the list price increase for Synacthen in March 2015. The previous Pharmaceutical Price Regulation Scheme, the current 2019 Voluntary Scheme for Branded Medicines Pricing and Access and our statutory branded medicines pricing scheme all have detailed arrangements for how companies can request an increase to the National Health Service list price for a product. Companies...

Written Answers — Department of Health and Social Care: NHS: Drugs (23 Jul 2019)

Seema Kennedy: The Medicines and Healthcare products Regulatory Agency investigates, or appropriately refers to another medicines self-regulatory body, complaints from any source about medicines advertising in relation to compliance with United Kingdom legislation.

Written Ministerial Statements — Department of Health and Social Care: Advancing our Health: Prevention in the 2020s (23 Jul 2019)

Seema Kennedy: Further to the Prevention Vision published on 5 November 2018, I wish to inform the House of the publication of the green paper, Advancing our Health: Prevention in the 2020s. The consultation will launch today and will run for 12 weeks. For the first 70 years of the NHS, we have been successful in helping people live longer. Life expectancy has increased by almost 30 years over the past...

Batten Disease (22 Jul 2019)

Seema Kennedy: I thank my hon. Friend for his question; he is a great champion for his constituents. We must ensure that all children with Batten disease receive world-class care and support. The Secretary of State has met families of children who suffer from the condition and has seen at first hand how cruel the disease can be. I pay tribute to my constituent Melanie Moffatt, whose amazing care for her...

Batten Disease (22 Jul 2019)

Seema Kennedy: I thank my hon. Friend for his questions. I will attempt to answer all of them. In terms of governance, no, NICE is not above accountability. Ministers set the framework for NICE, which is a non-departmental body. The reason it was established was to have fairness—so that there was no postcode lottery on access to various drugs. It is important that medical experts and scientists make these...

Batten Disease (22 Jul 2019)

Seema Kennedy: In answer to my hon. Friend the Member for North East Somerset (Mr Rees-Mogg), I urged BioMarin to get back around the table with NHSE and NICE and come to a fair and reasonable price. NICE has already approved drugs for 75% of rare diseases through its technology appraisal programme, including drugs for idiopathic pulmonary fibrosis and neuroblastoma. NICE’s process and review methods are...

Batten Disease (22 Jul 2019)

Seema Kennedy: I pay tribute to my hon. Friend and to the parents of Michal. This dreadful disease is so upsetting, not only for the children affected and their families, but for their wider communities. Health care in Wales is devolved. I again urge BioMarin to get back round the table, but I reassure my hon. Friend that I will make contact with the chief executive of NHS England to make sure that he is...

Batten Disease (22 Jul 2019)

Seema Kennedy: I thank the hon. Lady for her question. I know that she has spoken to me and spoken in this House about Nicole and Jessica Rich. I agree that it is a highly effective treatment, but NICE sets the guidelines because it is made up of the independent experts and they are the ones responsible for the number of QALYs. However, as I have already said, it is constantly reviewing its guidelines in...

Batten Disease (22 Jul 2019)

Seema Kennedy: I pay tribute to my hon. Friend for all the work she has done as a clinician. I can only say again—I know this is very disappointing for the House—that we have to rely on the NICE process to be independent. I hear what the House is saying with how some people having doubts about the process, but, again, it is under review. NICE is internationally respected, and it has been going for 20...

Batten Disease (22 Jul 2019)

Seema Kennedy: We are determined to improve treatments for people living with rare diseases. As the hon. Gentleman pointed out, they have to be treated differently because fewer people are affected by them. We have the rare diseases strategy, and we are trying to use genomics to better diagnose and treat diseases. We are trying to be the first health service to put genomics into day-to-day health delivery,...

Batten Disease (22 Jul 2019)

Seema Kennedy: I could not have put it better myself.

Batten Disease (22 Jul 2019)

Seema Kennedy: There will be co-operation with other medicines agencies, and I have no doubt that future co-operation will also come under any agreement that we reach with our European partners following our withdrawal from the European Union.

Batten Disease (22 Jul 2019)

Seema Kennedy: I completely agree with my hon. Friend. I have answered debates here and in Westminster Hall about the medical treatments for rare diseases. To reassure both patients and their families and Members of this place, we need to ensure that the review of NICE processes is robust and transparent.

Batten Disease (22 Jul 2019)

Seema Kennedy: We are putting record amounts of funding into the NHS, but I would rest again on the independence of the NICE process and the fact that it is experts and clinicians who are making these decisions. I agree that these are dreadful decisions and it is very hard for us to make them, which is why we rely on that expert advice. I would say to the hon. Gentleman that other jurisdictions are not...

Batten Disease (22 Jul 2019)

Seema Kennedy: I pay tribute to Kaycee and Liam. The hon. Lady makes a very important point. We want pharmaceutical companies to develop their medicines here, so that they are brought to the market here first and our constituents have access to them. However, we also have an obligation to spend taxpayers’ money in a very fair way, so that every penny we spend is done so correctly and appropriately. When...

Create an alert

Did you find what you were looking for?

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range


You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989


Enter a name here to restrict results to contributions only by that person.


Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.


If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.